Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iqvia Holdings Inc (IQV)

Iqvia Holdings Inc (IQV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector?

While Charles River Laboratories has underperformed its sector peers recently, analysts remain moderately optimistic about the stock’s prospects.

XLV : 144.77 (+0.02%)
CRL : 158.00 (+2.86%)
IQV : 166.96 (+0.54%)
3 Value Stocks We Steer Clear Of

3 Value Stocks We Steer Clear Of

LH : 264.42 (+0.54%)
FBRT : 8.77 (-0.68%)
IQV : 166.96 (+0.54%)
3 Mid-Cap Stocks We Keep Off Our Radar

3 Mid-Cap Stocks We Keep Off Our Radar

ACM : 90.06 (+1.67%)
BLD : 346.99 (+3.44%)
IQV : 166.96 (+0.54%)
IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

IQVIA Holdings Inc. (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced at NVIDIA GTC the launch of ...

IQV : 166.96 (+0.54%)
1 S&P 500 Stock Worth Your Attention and 2 We Question

1 S&P 500 Stock Worth Your Attention and 2 We Question

KO : 75.11 (+0.48%)
BMY : 57.00 (-0.84%)
IQV : 166.96 (+0.54%)
Is IQVIA Holdings Stock Underperforming the Nasdaq?

IQVIA Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

A : 112.02 (+0.65%)
$NASX : 21,946.76 (+1.38%)
IQV : 166.96 (+0.54%)
IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced...

IQV : 166.96 (+0.54%)
IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced...

IQV : 166.96 (+0.54%)
IQVIA Releases its 2025 Sustainability Report

IQVIA Holdings Inc. (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today published...

IQV : 166.96 (+0.54%)
3 Reasons to Sell IQV and 1 Stock to Buy Instead

3 Reasons to Sell IQV and 1 Stock to Buy Instead

IQV : 166.96 (+0.54%)

Barchart Exclusives

2 Safe Dividend Stocks to Buy and Hold Forever
These are two dividend stocks that you can confidently buy, hold, and forget about for decades. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.